Co-Founder and Chief Operating Officer
Dr. Matthew Boxer has more than 14 years of experience in biotech, and brings to Veralox experience in drug discovery, operations, strategy and finance. Prior to co-founding Veralox, he was a Group Leader at the NIH where he managed interdisciplinary teams consisting of internal and external stakeholders from biotech, academia and the government. Matt led numerous drug discovery projects with a focus on rare diseases and clinical unmet needs and he excels working at the interface of science, operations and finance.
Matthew earned a Bachelor of Science from the University of Vermont, followed by a Ph.D. in chemistry from the University of Chicago where he received multiple awards in research and teaching. After receiving his Ph.D. Matthew completed a Postdoctoral Fellowship within the Division of Preclinical Innovation at NIH followed by financial training from Johns Hopkins Carey School of Business.
Developing new therapies for life-threatening immuno-inflammatory diseases
Developing new therapies for life-threatening immuno-inflammatory diseases
Co-Founder and Chief Operating Officer
Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.
We found a number of people with your first name. When you find your first name in this list, select it